Managing Acne Among Individuals Receiving Masculinizing Hormone Therapy (MHT)
Masculinizing hormone therapy (MHT) represents a common therapeutic intervention for transgender men (female-to-male) and other gender diverse individuals. MHT typically involves the use of one of several forms of parenteral testosterone (e.g. gel, patch, intramuscular, pellet).1 The goal of MHT is to help develop masculine secondary sex characteristics and/or suppress feminine characteristics in …
Masculinizing hormone therapy (MHT) represents a common therapeutic intervention for transgender men (female-to-male) and other gender diverse individuals. MHT typically involves the use of one of several forms of parenteral testosterone (e.g. gel, patch, intramuscular, pellet).1 The goal of MHT is to help develop masculine secondary sex characteristics and/or suppress feminine characteristics in … Continue reading "Managing Acne Among Individuals Receiving Masculinizing Hormone Therapy (MHT)"
Morphea profunda. To the dermatologist, these words conjure images of hyperpigmented to violaceous, indurated, bound down atrophic plaques. We describe these lesions in our specialty’s vernacular, so that those we are conversing with can often surmise the diagnosis before even seeing the affected patient. But to the patient, it is the language of the diagnosis itself that has the most meaning. M … 
Well+Good recently published an article asking if hair loss supplements actually work.
For an expert opinion, I consulted Crystal Aguh, MD, Director of the Ethnic Skin Program and Assistant Professor in the Department of Dermatology at Johns Hopkins University School of Medicine, Baltimore, MD.
What is the theory behind hair supplements?
Hair supplements are designed to create an ideal nu … 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, is excited to share a new video series where dermatology key opinion leaders share important updates and pearls on a variety of medical, surgical, and aesthetic dermatology topics.
First up is Dr. Amy McMichael, Professor and Chair of Dermatology at the Wake Forest University School of Medicine, sharing … 
JDD Author and Senior Associate Editor, Dr. Leon Kircik, dives into the controversial and confusing landscape of in-office medication compounding.
In-office compounding, once part and parcel of dermatologic practice, has become increasingly controversial—and confusing. As a result of legitimate public health concerns, FDA scrutiny began with compounding facilities. Unfortunately, regulatory f …